Patient-specific time to peak abdominal organ enhancement varies with time to peak aortic enhancement at MR imaging

Radiology

Volumn 245, Issue 3, 2007, Pages 779-787

  Chu, Lisa L ^a   Joe, Bonnie N ^a   Westphalen, Antonio C A ^a   Webb, Emily M ^a   Coakley, Fergus V ^a   Yeh, Benjamin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL;

ABDOMEN; ABDOMINAL MASS; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AORTA; ARTICLE; BILE DUCT ATRESIA; BILIARY TRACT DISEASE; CHILD; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; JEJUNUM; JEJUNUM DISEASE; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREATITIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; STEATOSIS; TIME; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; CHILD; FEMALE; HUMANS; JEJUNUM; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 36248929487     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2451061585     Document Type: Article

References (56)

1. Mirowitz SA, Gutierrez E, Lee JK, Brown JJ, Heiken JP. Normal abdominal enhancement, patterns with dynamic gadolinium-enhanced MR imaging. Radiology 1991;180:637-640.
2. Frederick MG, McElaney BL, Singer A, et al. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate? AJR Am J Roentgenol 1996;166: 1305-1310.
3. Goshima S, Kanematsu M, Kondo H, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol 2006;187:W25-W32.
4. Kim T, Murakami T, Hori M, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol 2002;178:899-904.
5. Materne R, Horsmans Y, Jamart J, Smith AM, Gigot JF, Van Beers BE. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000;11:244-249.
6. Murakami T, Kim T, Kawata S, et al. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol 2003;38:497-503.
7. Shinozaki K, Yoshimitsu K, Irie H, et al. Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free procession magnetic resonance imaging. J Comput Assist Tomogr 2004;28: 628-634.
8. Silverman PM, O'Malley J, Tefft MC, Cooper G, Zeman RK. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning. AJR Am J Roentgenol 1995;164: 619-623.
9. Van Beers BE, Materne R, Lacrosse M, et al. MR imaging of hypervascular liver tumors: timing optimization during the arterial phase. J Magn Reson Imaging 1999;9:562-567.
10. Yu JS, Kim KW, Jo BJ, et al. Test-bolus injection for optimization of arterial phase imaging during contrast-enhanced hepatic MR imaging. Yonsei Med J 2000;41:459-467.
11. Boland GW, O'Malley ME, Saez M, Fernandez-del-Castillo C, Warshaw AL, Mueller PR. Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 1999:172:605-608.
12. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 1998;206:373-378.
13. Graf O, Boland GW, Warshaw AL, Fernandez-del-Castillo C, Hahn PF, Mueller PR. Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy. AJR Am J Roentgenol 1997;169:119-123.
14. Lu DS, Vedantham S, Krasny RM, Kadell B, Berger WL, Reber HA. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 1996;199:697-701.
15. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-662.
16. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. I. Prediction with a computer model. Radiology 1998;207:647-655.
17. Francois CJ, Shors SM, Bonow RO, Finn JP. Analysis of cardiopulmonary transit times at contrast material-enhanced MR imaging in patients with heart disease. Radiology 2003; 227:447-452.
18. Paulson EK, Fisher AJ, DeLong DM, Parker DD, Nelson RC. Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? Radiology 1998;209:787-792.
19. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
20. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996; 201:705-710.
21. Foo TK, Saranathan M, Prince MR, Chenevert TL. Automated detection of bolus arrival arrd initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 1997;203:275-280.
22. Hany TF, McKinnon GC, Leung DA, Pfammatter T, Debatin JF. Optimization of contrast timing for breath-hold three-dimensional MR angiography. J Magn Reson Imaging 1997;7:551-556.
23. Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH. Contrast-enhanced abdominal MR angiography, optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 1997;203:109-114.
24. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
25. Cademartiri F, Nieman K, van der Lugt A, et al. Intravenous contrast material administration at 16-detector row helical CT coronary angiography: test bolus versus bolus-tracking technique. Radiology 2004;233: 817-823.
26. van Hoe L, Marchal G, Baert AL, Gryspeerdt S, Mertens L. Determination of scan delay tune in spiral CT-angiography: utility of a test bolus injection. J Comput Assist Tomogr 1995;19:216-220.
27. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997;202:268-273.
28. Hussain HK, Londy FJ, Francis IR, et al. Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology 2003;226:558-566.
29. Kanematsu M, Semelka RC, Matsuo M, et al. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases - a prospective randomized study in patients with chronic liver damage. Radiology 2002;225: 407-415.
30. Kim MJ, Chung YE, Kim KW, et al. Variation of the time to aortic enhancement of fixed-duration versus fixed-rate injection protocols. AJR Am J Roentgenol 2006;186: 185-192.
31. Mehnert F, Pereira PL, Trubenbach J, Kopp AF, Claussen CD. Biphasic spiral CT of the liver: automatic bolus tracking or time delay? Eur Radiol 2001;11:427-431.
32. Shimizu T, Misaki T, Yamamoto K, Sueyoshi K, Narahayashi I. Helical CT of the liver with computer-assisted bolus-tracking technology: scan delay of arterial phase scanning and effect of flow rates. J Comput Assist Tomogr 2000;24: 219-223.
33. Pinheiro JC, Bates DM. Extending the basic linear mixed-effects model. In: Mixed-effects models in S and S-PLUS. New York, NY: Springer Verlag, 2000; 206-225.
34. Chung YE, Kim KW, Kim JH, et al. Optimal delay time for the hepatic parenchymal enhancement at the muitidetector CT examination. J Comput Assist Tomogr 2006;30:182-188.
35. Herts BR, Paushter DM, Einstein DM, Zepp R, Friedman RA, Obuchowski N. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times. AJR Am J Roentgenol 1995;164:327-331.
36. Hollett MD, Jorgensen MJ, Jeffrey RB Jr. Quantitative evaluation of pancreatic enhancement during dual-phase helical CT. Radiology 1995;195:359-361.
37. Silverman PM, Roberts S, Tefft MC, et al. Helical CT of the liver: clinical application of an automated computer technique, Smart-Prep. for obtaining images with optimal contrast enhancement. AJR Am J Roentgenol 1995;165:73-78.
38. Vignaux O, Legmann P, Coste J, Hoeffel C, Bonnin A. Cirrhotic liver enhancement on dual-phase helical CT: comparison with non-cirrhotic livers in 146 patients. AJR Am J Roentgenol 1999;173:1193-1197.
39. Kanematsu M, Shiratori Y, Hoshi H, Kondo H, Matsuo M, Moriwaki H. Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR imaging. Radiology 2000;215:95-102.
40. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 1994;163:323-331.
41. Dinkel HP, Fieger M, Knupffer J, Moll R, Schindler G. Optimizing liver contrast in helical liver CT: value of a real-time bolus-triggering technique. Eur Radiol 1998;8:1608-1612.
42. Kopka L, Rodenwaldt J, Fischer U, Mueller DW, Oestmann JW, Grabbe E. Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material. Radiology 1996;201:321-326.
43. Murakami T, Onishi H, Mikami K, et al. Determining the optimal timing for early arterial phase hepatic CT imaging by measuring abdominal aortic enhancement in variable contrast injection protocols. J Comput Assist Tomogr 2006;30:206-211.
44. Itoh S, Ikeda M, Achiwa M, Satake H, Iwano S, Ishigaki T. Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: automatic bolus tracking or empirical scan delay? Eur Radiol 2004;14: 1665-1673.
45. Sandstede JJ, Tschammler A, Beer M, Vogelsang C, Wittenberg G, Hahn D. Optimization of automatic bolus tracking for timing of the arterial phase of helical liver CT. Eur Radiol 2001;11:1396-1400.
46. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate - pharmacokinetic analysis and experimental porcine model. Radiology 1998;206:455-464.
47. Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996; 167:753-757.
48. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol 1999;172:53-56.
49. Garcia PA, Bonaldi VM, Bret PM, Liang L, Reinhold C, Atri M. Effect of rate of contrast medium injection on hepatic enhancement at CT. Radiology 1996;199:185-189.
50. Awai K, Hori S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 2003;13:2155-2160.
51. Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004;230: 142-150.
52. Kanematsu M, Goshima S, Kondo H, et al. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 2005; 29:195-201.
53. Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multidetector row helical CT. Radiology 2002; 224:757-763.
54. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multidetector row helical CT. Radiology 2001; 218:763-767.
55. Noguchi Y, Murakami T, Kim T, et al. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase. J Comput Assist Tomogr 2002;26: 981-987.
56. Kim MJ, Choi JY, Lim JS, et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR Am J Roentgenol 2006;187: 198-206.